More about

Weight Loss

News
March 28, 2023
3 min read
Save

Weight regain does not erode cardiometabolic benefits of weight-loss programs

Weight regain does not erode cardiometabolic benefits of weight-loss programs

Participants in behavioral weight-loss programs improved several CV risk factors for at least 5 years after an intervention ended, despite weight regain, compared with low-intensity programs or controls, researchers reported.

News
March 23, 2023
2 min read
Save

GLP-1/glucagon dual agonist linked to 10% weight loss in half of adults with obesity

GLP-1/glucagon dual agonist linked to 10% weight loss in half of adults with obesity

About half of adults taking a novel peptide-based GLP-1/glucagon dual receptor agonist in development for the treatment of obesity in nonalcoholic steatohepatitis lost 10% or more body weight at 24 weeks, according to a press release.

News
March 14, 2023
2 min read
Save

Sleep quality may affect adherence to exercise, diet goals in those trying to lose weight

Sleep quality may affect adherence to exercise, diet goals in those trying to lose weight

Improved domains of sleep quality may improve patients’ ability to adhere to components of a behavioral weight-loss intervention, including exercise and diet goals, a speaker reported.

News
March 13, 2023
2 min read
Save

Ozempic for rapid weight loss may result in facial sagging, drooping

Ozempic for rapid weight loss may result in facial sagging, drooping

Taking Ozempic may result in a side effect coined the “Ozempic face drop,” according to Konstantin Vasyukevich, MD, a private facial plastic surgeon in New York.

News
March 06, 2023
2 min read
Save

People with NAFLD who exercise are 3.5 times more likely to achieve liver fat reduction

People with NAFLD who exercise are 3.5 times more likely to achieve liver fat reduction

Physically active patients with nonalcoholic fatty liver disease were more likely to achieve at least a 30% reduction in MRI-measured liver fat, according to research in The American Journal of Gastroenterology.

News
February 16, 2023
3 min read
Save

Once-weekly semaglutide improves eating control behaviors among adults with obesity

Once-weekly semaglutide improves eating control behaviors among adults with obesity

Once-weekly semaglutide 2.4 mg is associated with reductions in hunger and improved fullness at 20 weeks as well as improved craving control at 2 years, according to findings from the STEP 5 randomized controlled trial.

News
February 16, 2023
10 min read
Save

Phenotyping, genetics hold keys to precision medicine in obesity treatment

Phenotyping, genetics hold keys to precision medicine in obesity treatment

From bariatric surgery to lifestyle interventions to medications, there are several options available for treating obesity. However, determining the treatment plan that works best for each person remains a challenge.

News
February 16, 2023
3 min read
Save

Does time-restricted eating confer clinically significant health benefits for adults?

Does time-restricted eating confer clinically significant health benefits for adults?

There are many benefits of time-restricted eating and many mechanisms that may play a role. It has been shown that time-restricted eating affects the gut microbiome. When we restrict our eating window to only a certain period during the day, it increases the diversity of the gut microbiome and also affects the composition. We know that our gut microbiome may affect our insulin sensitivity and our immune function, and it may have beneficial effects on our cardiovascular system.

News
February 13, 2023
6 min read
Save

Perinatal weight stigma delays care, disrupts trust

Perinatal weight stigma delays care, disrupts trust

Bias based on size during pregnancy is a common experience particularly for women with overweight or obesity and can delay prenatal and postnatal care for women who fear weight stigma in the health care setting, according to experts.

News
February 07, 2023
2 min read
Save

33% of adults with type 2 diabetes lost 5% or more of body weight with GLP-1 agonists

33% of adults with type 2 diabetes lost 5% or more of body weight with GLP-1 agonists

About one-third of adults who were prescribed a GLP-1 receptor agonist to treat type 2 diabetes lost at least 5% of their body weight at 72 weeks, according to findings from a real-world retrospective analysis.

View more